INMB INmune Bio, Inc.
Healthcare$1.43-1.38%ClosedMarket Cap: $38.0M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$22.00
Target (Median)
$22.00
Target Range
$22.00 - $22.00
Upside from current price: 1438.5%
Rating Distribution
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-11 | LUCID CAPITAL MARKETS | upgrade | Buy | Neutral |
| 2025-07-02 | Maxim Group | maintain | Buy | Buy |
| 2025-07-01 | BTIG | downgrade | Neutral | Buy |
| 2025-07-01 | Scotiabank | downgrade | Sector Underperform | Sector Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.94 | $133.3K | 2 |
| Fri Dec 31 | $-0.76 | $6.4M | 2 |
| Sun Dec 31 | $-0.50 | $25.1M | 2 |
| Mon Dec 31 | $0.69 | $96.6M | 1 |